Hepatitis D screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 6: | Line 6: | ||
==Screening== | ==Screening== | ||
All patients with current or previous [[IV drug use]] history should be evaluated for [[hepatitis B]]. However, [[screening]] is not recommended in [[asymptomatic]] [[HBsAg]] positive patients. | All patients with current or previous [[IV drug use]] history should be evaluated for [[hepatitis B]]. However, [[screening]] is not recommended in [[asymptomatic]] [[HBsAg]] positive patients. The following preventive measures and [[screening]] may be applied: | ||
*Patients who have acute hepatitis B, are not [[HBsAg]] positive and who are [[IgM]] anti-HBc positive may be tested for [[HDV]]. | *Patients who have acute hepatitis B, are not [[HBsAg]] positive and who are [[IgM]] anti-HBc positive may be tested for [[HDV]]. | ||
*Patients with positive [[HBsAg]] and/or HDV antibody should be alerted not to share items such as razors | *Patients with positive [[HBsAg]] and/or HDV antibody should be alerted not to share items such as razors or eating and drinking utensils. | ||
*Patients without [[immunity]] to | *Patients without [[immunity]] to HBV should be [[vaccinated]]. | ||
The general population, without risk for [[HBV]] and /or [[HDV]], does not need [[screening]]. | The general population, without risk for [[HBV]] and /or [[HDV]], does not need [[screening]]. | ||
Attending to the life cycle of [[HDV]], and the potential [[complications]] of [[infection]] with this [[virus]], the following [[screening]] recommendations should be applied: | Attending to the life cycle of [[HDV]], and the potential [[complications]] of [[infection]] with this [[virus]], the following [[screening]] recommendations should be applied: | ||
Blood products should also be screened for the presence of [[HDV]] and HBV, to prevent infection by [[blood transfusion]] and [[hemodialysis]].<ref name="pmid21511329">{{cite journal| author=Hughes SA, Wedemeyer H, Harrison PM| title=Hepatitis delta virus. | journal=Lancet | year= 2011 | volume= 378 | issue= 9785 | pages= 73-85 | pmid=21511329 | doi=10.1016/S0140-6736(10)61931-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21511329 }} </ref> | |||
For recommendations regarding HBV and HCC screening, refer to [[Hepatitis B screening]]<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref> | For recommendations regarding HBV and HCC screening, refer to [[Hepatitis B screening]]<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref> | ||
==References== | ==References== | ||
Revision as of 14:59, 6 August 2014
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D screening On the Web |
|
American Roentgen Ray Society Images of Hepatitis D screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]
Overview
Screening
All patients with current or previous IV drug use history should be evaluated for hepatitis B. However, screening is not recommended in asymptomatic HBsAg positive patients. The following preventive measures and screening may be applied:
- Patients who have acute hepatitis B, are not HBsAg positive and who are IgM anti-HBc positive may be tested for HDV.
- Patients with positive HBsAg and/or HDV antibody should be alerted not to share items such as razors or eating and drinking utensils.
- Patients without immunity to HBV should be vaccinated.
The general population, without risk for HBV and /or HDV, does not need screening.
Attending to the life cycle of HDV, and the potential complications of infection with this virus, the following screening recommendations should be applied:
Blood products should also be screened for the presence of HDV and HBV, to prevent infection by blood transfusion and hemodialysis.[1]
For recommendations regarding HBV and HCC screening, refer to Hepatitis B screening[2]
References
- ↑ Hughes SA, Wedemeyer H, Harrison PM (2011). "Hepatitis delta virus". Lancet. 378 (9785): 73–85. doi:10.1016/S0140-6736(10)61931-9. PMID 21511329.
- ↑ Lok AS, McMahon BJ (2004). "[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]" (PDF). Romanian Journal of Gastroenterology. 13 (2): 150–4. PMID 15229781. Retrieved 2012-02-10. Unknown parameter
|month=ignored (help)